Gastrointestinal

Displaying 1 - 5 of 5


A Novel, Human-Derived HER2 Antibody for Cancer Therapeutics and Diagnostics

Vanderbilt researchers have discovered a human-derived antibody that recognizes HER2, a protein overexpressed in various cancers. These antibodies offer potential novel cancer therapeutics and diagnostic tools with improved immunological compatibility compared to humanized antibody alternatives.


Licensing Contact

Cameron Sargent

615.322.5907
Antibody
Antibody

Oxygen-Tolerant Probiotic Therapy for Intestinal Inflammatory Diseases

Vanderbilt researchers have engineered Bacteroides thetaiotaomicron, an obligate anaerobe, to endure oxygen-rich conditions in the gut, enhancing the survival and functionality of these probiotics used to treat inflammation.


Licensing Contact

Cameron Sargent

615.322.5907

Bedside Disposable Endoscope

Bedside Disposable Endoscope


Licensing Contact

Masood Machingal

615.343.3548
Medical Devices
Gastrointestinal

Inexpensive Disposable Hydro-Jet Capsule Robot for Gastric Cancer Screening in Low-Income Countries

Gastric cancer is the second leading cause of cancer death worldwide. While screening programs have had a tremendous impact on reducing mortality, the majority of cases occur in low and middle-income countries (LMIC). Typically, screening for gastric and esophageal cancer is performed using a flexible endoscope; however, endoscopy resources for these settings are traditionally limited. With the development of an inexpensive, disposable system by Vanderbilt researchers, gastroscopy and colonoscopy can be facilitated in areas hampered by a lack of access to the appropriate means.


Licensing Contact

Masood Machingal

615.343.3548

Prevention of Cytokine Induced Apoptosis In Intestinal Epithelial Cells By A Probiotic Bacterium

The present invention provides therapeutic and prophylactic compositions for use in treating and preventing disorders involved epithelial cell apoptosis, such as gastrointestinal disorders (e.g., inflammatory bowel disease, Crohn's disease or ulcerative colitis) in a subject, such as a human patient.


Licensing Contact

Mike Villalobos

615.322.6751

Inventors

Brent Polk, Fang Yan
Therapeutics
Gastrointestinal
Protein/Peptide